📰 Chas Schultz News
Chas Schultz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chas Schultz. Real-time updates on events, politics, business and more.
January 10, 2024
SAN DIEGO, Jan. 10, 2024 -- Crinetics Pharmaceuticals, Inc. today announced that on January 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock...
January 10, 2024
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, the Compensation...
January 3, 2024
SAN DIEGO, Jan. 03, 2024 -- Crinetics Pharmaceuticals, Inc. today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, will present at the 42nd Annual J.P....
December 18, 2023
Significant Reductions in Frequency and Intensity of Both Bowel Movements and Flushing Episodes Were Observed Paltusotine was Well-Tolerated with an Overall Pharmacokinetic Profile that was...
November 20, 2023
SAN DIEGO, Nov. 20, 2023 -- Crinetics Pharmaceuticals, Inc. today announced that company management will participate in fireside chats at the 6th Annual Evercore ISI HealthCONx Conference in...
November 10, 2023
SAN DIEGO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...
November 10, 2023
SAN DIEGO, Nov. 10, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare...
October 10, 2023
SAN DIEGO, Oct. 10, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare...
September 20, 2023
SAN DIEGO, Sept. 20, 2023 -- Crinetics Pharmaceuticals, Inc. today announced that company management will participate in a fireside chat and 1x1 investor meetings at the Cantor Global Healthcare...
September 13, 2023
SAN DIEGO, Sept. 12, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for...